Endometriosis Blood Test: An End to Years of Agony? - Summary - MDSpire
From the Journals

Endometriosis Blood Test: An End to Years of Agony?

Multi-omic assay could reduce reliance on surgery and imaging

  • April 9, 2026

  • 3 min

Share

A novel multi-marker blood test is emerging as a breakthrough in endometriosis diagnosis, providing an accurate detection of the disease through microRNA, protein, and hormone measurements. Affecting 5-10% of women of reproductive age, endometriosis often goes misdiagnosed for years, with traditional methods like laparoscopic surgery being invasive and dependent on operator skill. This new assay integrates seven biomarkers and utilizes machine learning for disease classification, presenting a significant advancement in identifying cases often missed by standard imaging. Published in the Journal of Minimally Invasive Gynecology, this innovation signals a path towards earlier diagnosis and intervention, reducing reliance on invasive techniques.

Original Source(s)

Endometriosis Blood Test: An End to Years of Agony?

  • April 9, 2026

Related Content

FDA Clears At-Home HPV Screening Tool

Self-collection approach aims to expand screening access

‘4-Minute Rule’ Guides Cesarean Timing

Physiologic mechanisms and team coordination inform management during maternal cardiac arrest

Hidden Pain After Mastectomy?

Chronic postsurgical pain affects many patients but is often underdiagnosed and undertreated.